中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
NSC366140无结构图 |
Pyrazoloacridine |
99009-20-8 |
C19H21N5O3 |
|
NSC23766三盐酸盐 |
NSC 23766 trihydrochloride |
1177865-17-6 |
C24H38Cl3N7 |
|
NSC 348884; N1,N1,N2,N2-四[(6-甲基-1H-苯并咪唑-2-基)甲基]-1,2-乙二胺 |
N,N,N',N'-tetrakis[(6-methyl-1H-benzimidazol-2-yl)methyl]ethane-1,2-diamine |
81624-55-7 |
C38H40N10 |
|
NSC 317629; 1-[4-[4-[[2-(2,4-二氯苯基)-2-(1H-咪唑-1-甲基)-1,3-二氧杂环戊-4-基]甲氧基]苯基]-1-哌嗪基]乙酮 |
ketokonazole |
65277-42-1 |
C26H28Cl2N4O4 |
|
NS8593盐酸盐 |
NS 8593 hydrochloride |
875755-24-1 |
C17H17N3*ClH |
|
NPS2143盐酸盐 |
NPS 2143 hydrochloride |
324523-20-8 |
C24H25ClN2O2*ClH |
|
NPC-15437二盐酸盐 |
NPC 15437 |
136449-85-9 |
C25H50N4O2 |
|
NOTA-BIS(叔丁基酯) |
2-(4,7-bis(2-(tert-butoxy)-2-oxoethyl)-1,4,7-triazonan-1-yl)acetic acid |
1161415-28-6 |
C20H37N3O6 |
|
NO-泼尼松龙 |
prednisolone 21-[(4’-nitro-oxymethyl)benzoate] |
327610-87-7 |
C29H33NO9 |
|
NO-冯-PDETMPPI |
NO-Feng-PDEtMPPi |
1502814-74-5 |
C37H56N4O4 |
|
NN-二甲基哌啶-4-胺盐酸盐 |
N,N-dimethylpiperidin-4-amine dihydrochloride |
172281-90-2 |
C7H16N2*2ClH |
|
NN-二甲基-L-丙氨酸 |
N,N-dimethyl-L-alanine |
2812-31-9 |
C5H11NO2 |
|
NN-二乙基-2-哌嗪-1-基烟碱 |
N,N-Diethyl-2-Piperazin-1-Yl-Nicotinamide |
902836-85-5 |
C14H22N4O |
|
NN-[(1,1-二甲基乙氧基)羰基]-4-[(甲基磺酰基)氨基]-L-苯基丙氨酸 |
N-t-butoxycarbonyl-DL-4-(methylsulfonylamino)phenylalanine |
204856-74-6 |
C15H22N2O6S |
|
NLG-919中间体4 |
1-cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethanone |
1402838-89-4 |
C18H20N2O |
|
NLG-919中间体 |
2-(1-trityl-1H-imidazol-4-yl)benzaldehyde |
1402838-08-7 |
C29H22N2O |
|
NKH477(达福尔考辛) |
NKH 477 |
138605-00-2 |
C27H43NO8*ClH |
|
NK110树脂 |
N-Ethyl-N'-propyl-piperazin |
90796-44-4 |
C9H20N2 |
|
NK-611盐酸盐 |
VP 19 Hydrochloride |
105760-98-3 |
C31H38ClNO12 |
|
NK-1拮抗剂1 |
(3S,6S)-6-({(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-3-(5-oxo-1,5dihydro-4H-1,2,4-triazol-4-yl)-6-phenylpiperidine-3-carbonitrile |
873947-10-5 |
C25H23F6N5O2 |
|
NI(a)-类似的蛋白质 |
hydron;N-methyl-3-(2-phenylphenoxy)propan-1-amine;chloride |
—— |
C16H20ClNO |
|
NHS-双吖丙啶 |
2,5-dioxopyrrolidin-1-yl 3-(3-methyl-3H-diazirin-3-yl)propanoate |
1239017-80-1 |
C9H11N3O4 |
|
NHPI-四聚乙二醇-C2-琥珀酰亚胺酯 |
2,5-dioxopyrrolidin-1-yl 1-((1,3-dioxoisoindolin-2-yl)oxy)-3,6,9,12-tetraoxapentadecan-15-oate |
1415328-95-8 |
C23H28N2O11 |
|
NHC-PD(II)-IM催化剂 |
methyl (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-3,5-dihydroxy-6-methyl-4-[methyl-[[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methyl]amino]oxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylate |
1314876-23-7 |
C55H87NO22 |
|
NH-双(四聚乙二醇-羟基) |
NH-bis(PEG4-OH) |
63721-06-2 |
C20H43NO10 |
|
NH-双(二聚乙二醇-羟基) |
3,6,12,15-tetraoxa-9-azaheptadecane-1,17-diol |
25743-12-8 |
C12H27NO6 |
|
NH-双(三聚乙二醇-叠氮) |
bis(2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl)amine |
1258939-39-7 |
C16H33N7O6 |
|
NH-BIS(一聚乙二醇-羟基) |
3,9-dioxa-6-azaundecane-1,11-diol |
54384-47-3 |
C8H19NO4 |
|
NG-单甲基-L-精氨酸醋酸盐 |
NG-monomethyl-L-arginine monoacetate |
53308-83-1 |
C2H4O2*C7H16N4O2 |
|
NF-κB活化抑制剂VI |
2-phenylimino-4-oxo-4,5,6,7-tetrahydro-6,6-dimethyl-1,3-benzoxathiole |
113760-29-5 |
C15H15NO2S |
|
NDI-双C8C12-双噻吩-双溴 |
N,N′-bis(2-octyldodecyl)-2,6-bis(5-bromothiophenyl-5-yl)-1,4,5,8-naphthalene diimide |
1178586-27-0 |
C62H88Br2N2O4S2 |
|
ND-646中间体 |
(R)-2-(2-methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethan-1-ol |
1434652-66-0 |
C14H20O4 |
|
NBI35965盐酸盐 |
NBI-35965 Mesylate |
603151-83-3 |
C22H26Cl2N4O3S |
|
NBD-双十六胺 |
4-Benzofurazanamine, N,N-dihexadecyl-7-nitro- |
117056-66-3 |
C38H68N4O3 |
|
NBD-CO-HZ[=4-(N-肼羰甲基-N-甲氨基)-7-硝基-2,1,3-苯并恶二唑] |
4-(N-hydrazinocarbonylmethyl-N-methylamino)-7-nitro-2,1,3-benzoxadiazole |
221263-97-4 |
C9H10N6O4 |
|
NBD-556; N-(4-氯苯基)-N'-(2,2,6,6-四甲基哌啶-4-基)草酰胺 |
NBD-556 |
333353-44-9 |
C17H24ClN3O2 |
|
NA无结构图 |
7-amino-5-(4-methoxy-benzyl)-5H,7H-dibenzo[b,d]azepin-6-one hydrochloride |
1083065-04-6 |
C22H20N2O2*ClH |
|
NA无结构图 |
5-(4-methoxybenzyl)-5H-dibenzo[b,d]azepin-6(7H)-one |
847926-44-7 |
C22H19NO2 |
|
NAlpha-芴甲氧羰基-O-三苯代甲基-L-增丝氨酸 |
N<sup>α</sup>-Fmoc-O-Trt-Hse |
111061-55-3 |
C38H33NO5 |
|
NAlpha-芴甲氧羰基-Nγ-羰-L-2,4-氨基丁酸 |
(S)-4-tert-butoxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)butyric acid |
125238-99-5 |
C24H28N2O6 |
|
NAlpha-甘氨酰-DL-天冬酰胺 |
glycyl-DL-asparagine |
32729-21-8 |
C6H11N3O4 |
|
NAlpha-叔丁氧羰基-Nim-苄基-L-组氨酸 |
Boc-His(Bzl)-OH |
20898-44-6 |
C18H23N3O4 |
|
NAlpha-FMOC-Nω-PMC-D-精氨酸 |
Fmoc-D-Arg(Pmc)-OH |
157774-30-6 |
C35H42N4O7S |
|
NAlpha-CBZ-L-精氨酸盐酸盐 |
N<sup>α</sup>-Z-L-arginine hydrobromide |
73496-41-0 |
BrH*C14H20N4O4 |
|
NAlpha-(5-氟-2,4-二硝基苯基)-L-亮氨酰胺 |
N-(5-fluoro-2,4-dinitrophenyl)-L-leucinamide |
178065-29-7 |
C12H15FN4O5 |
|
NAlpha-(2,4-二硝基-5-氟苯基)-D-亮氨酰铵 |
D-FDLA |
178065-30-0 |
C12H15FN4O5 |
|
NAlpha(叔丁氧基羰基)-L-精氨酸-4-硝基苯胺盐酸盐 |
Boc-Arg-pNA*HCl |
99306-64-6 |
C17H26N6O5*ClH |
|
NARIRUTIN4'-葡萄糖苷 |
Narirutin 4'-O-glucoside |
17257-22-6 |
C33H42O19 |
|
NAMPT抑制剂(CB30865) |
CB 30865 |
206275-15-2 |
C26H22BrN5O2 |
|
NAFION@膜,0.05MM厚,磺酰氟型 |
1,1,2,2-Tetrafluoroethene; 1,1,2,2-tetrafluoro-2-[1,1,1,2,3,3-hexafluoro-3-(1,2,2-trifluoroethenoxy)propan-2-yl]oxyethanesulfonyl fluoride |
26654-97-7 |
C9F18O4S |
|